WEKO3
アイテム
{"_buckets": {"deposit": "a5689c4e-0b66-415e-b51a-b24c46fc9ec6"}, "_deposit": {"created_by": 1, "id": "82336", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "82336"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00082336", "sets": ["1"]}, "author_link": ["1015780", "1015778", "1015779", "1015776", "1015774", "1015782", "1015777", "1015775", "1015781"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2021-02", "bibliographicIssueDateType": "Issued"}, "bibliographicPageStart": "624786", "bibliographicVolumeNumber": "11", "bibliographic_titles": [{"bibliographic_title": "Frontiers in oncology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Research into high linear energy transfer (LET) radiotherapy now spans over half a century, beginning with helium and deuteron treatment in 1952 and today ranging from fast neutrons to carbon-ions. Owing to pioneering work initially in the United States and thereafter in Germany and Japan, increasing focus is on the carbon-ion beam: 12 centers are in operation, with five under construction and three in planning. While the carbon-ion beam has demonstrated unique and promising suitability in laboratory and clinical trials toward the hypofractionated treatment of hypoxic and/or radioresistant cancer, substantial developmental potential remains. Perhaps most notable is the ability to paint LET in a tumor, theoretically better focusing damage delivery within the most resistant areas. However, the technique may be limited in practice by the physical properties of the beams themselves. A heavy-ion synchrotron may provide irradiation with multiple heavy-ions: carbon, helium, and oxygen are prime candidates. Each ion varies in LET distribution, and so a methodology combining the use of multiple ions into a uniform LET distribution within a tumor may allow for even greater treatment potential in radioresistant cancer. ", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Frontiers in oncology"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "33692957", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.3389/fonc.2021.624786", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.frontiersin.org/articles/10.3389/fonc.2021.624786/full", "subitem_relation_type_select": "URI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "2234-943X", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Ebner, Daniel"}], "nameIdentifiers": [{"nameIdentifier": "1015774", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "J. Frank, Steven"}], "nameIdentifiers": [{"nameIdentifier": "1015775", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Taku, Inaniwa"}], "nameIdentifiers": [{"nameIdentifier": "1015776", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shigeru, Yamada"}], "nameIdentifiers": [{"nameIdentifier": "1015777", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Toshiyuki, Shirai"}], "nameIdentifiers": [{"nameIdentifier": "1015778", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ebner, Daniel", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1015779", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Taku, Inaniwa", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1015780", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Shigeru, Yamada", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1015781", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Toshiyuki, Shirai", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1015782", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "The Emerging Potential of Multi-Ion Radiotherapy ", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The Emerging Potential of Multi-Ion Radiotherapy "}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/82336", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-03-22"}, "publish_date": "2021-03-22", "publish_status": "0", "recid": "82336", "relation": {}, "relation_version_is_last": true, "title": ["The Emerging Potential of Multi-Ion Radiotherapy "], "weko_shared_id": -1}
The Emerging Potential of Multi-Ion Radiotherapy
https://repo.qst.go.jp/records/82336
https://repo.qst.go.jp/records/823362fa5cd3e-8596-426f-82c4-65723e3b9d89
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-03-22 | |||||
タイトル | ||||||
タイトル | The Emerging Potential of Multi-Ion Radiotherapy | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Ebner, Daniel
× Ebner, Daniel× J. Frank, Steven× Taku, Inaniwa× Shigeru, Yamada× Toshiyuki, Shirai× Ebner, Daniel× Taku, Inaniwa× Shigeru, Yamada× Toshiyuki, Shirai |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Research into high linear energy transfer (LET) radiotherapy now spans over half a century, beginning with helium and deuteron treatment in 1952 and today ranging from fast neutrons to carbon-ions. Owing to pioneering work initially in the United States and thereafter in Germany and Japan, increasing focus is on the carbon-ion beam: 12 centers are in operation, with five under construction and three in planning. While the carbon-ion beam has demonstrated unique and promising suitability in laboratory and clinical trials toward the hypofractionated treatment of hypoxic and/or radioresistant cancer, substantial developmental potential remains. Perhaps most notable is the ability to paint LET in a tumor, theoretically better focusing damage delivery within the most resistant areas. However, the technique may be limited in practice by the physical properties of the beams themselves. A heavy-ion synchrotron may provide irradiation with multiple heavy-ions: carbon, helium, and oxygen are prime candidates. Each ion varies in LET distribution, and so a methodology combining the use of multiple ions into a uniform LET distribution within a tumor may allow for even greater treatment potential in radioresistant cancer. | |||||
書誌情報 |
Frontiers in oncology 巻 11, p. 624786, 発行日 2021-02 |
|||||
出版者 | ||||||
出版者 | Frontiers in oncology | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 2234-943X | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 33692957 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.3389/fonc.2021.624786 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://www.frontiersin.org/articles/10.3389/fonc.2021.624786/full |